Camel-IDS is a biotech company developing targeted radionuclide therapeutic solutions against cancer. Camel-IDS was incorporated on October 14th 2014 in Brussels, Belgium to leverage a technology platform that has been developed at VUB (Vrije Universiteit Brussel). Camel-IDS is based on recombinant, small antigen-binding fragments derived from Camelidae heavy-chain-only antibodies (Camelids), coupled with a therapeutic radioisotope. Camelids are used to transport the radioisotope to selected cancer receptors on the cancer cell surface and will selectively kill cancer cells by irradiation.
View Top Employees from Camel-IDS NV| Website | http://camel-ids.com |
| Revenue | $11.8 million |
| Funding | $117.8 million |
| Employees | 39 (39 on RocketReach) |
| Founded | 2014 |
| Address | 1 Burgemeester Etienne Demunterlaan, Bruxelles Jette, Brussels Capital 1090, BE |
| Phone | (322) 479-9360 |
| Industry | Biotechnology, Research, Pharmaceuticals, Healthcare, Science and Engineering |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 54 Companies, NAICS Code 32541 Companies |
Looking for a particular Camel-IDS NV employee's phone or email?
Camel-IDS NV Questions
The Camel-IDS NV annual revenue was $11.8 million in 2024.
Dimitrios Mantzilas is the CTO of Camel-IDS NV.
39 people are employed at Camel-IDS NV.
Camel-IDS NV is based in Bruxelles Jette, Brussels Capital.
The NAICS codes for Camel-IDS NV are [541, 32, 3254, 325, 54, 32541].
The SIC codes for Camel-IDS NV are [283, 28].
Top Camel-IDS NV Employees
-
11
-
5+1
-
4
-
44
-
2
